BMI and Contraceptives Affect New Age-, Sex-, and Puberty-adjusted IGF-I and IGFBP-3 Reference Ranges Across Life Span

BMI and Contraceptives Affect New Age-, Sex-, and Puberty-adjusted IGF-I and IGFBP-3 Reference Ranges Across Life Span

CONTEXT: Various clinical factors influencing serum levels of insulin-like growth factor I (IGF-I) and its binding protein 3 (IGFBP-3) are not entirely consistently described. OBJECTIVE: We asked whether body mass index (BMI), contraceptive drugs (CDs), and hormone replacement therapy (HRT) have pot...

Full description

Bibliographic Details
Main Authors: Ceglarek, U. (Author), Hörenz, C. (Author), Kiess, W. (Author), Kratzsch, J. (Author), Pfäffle, R. (Author), Thiery, J. (Author), Vogel, M. (Author), Wirkner, K. (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Subjects:
adolescent
Adolescent
adult
Adult
BMI
body mass
Body Mass Index
child
Child
childhood obesity
contraceptive agent
Contraceptive Agents
contraceptive drugs
gestagen
human
Humans
IGFBP-3
IGF-I
Insulin-Like Growth Factor Binding Protein 3
Insulin-Like Growth Factor Binding Proteins
Insulin-Like Growth Factor I
longevity
Longevity
metabolism
obesity
Pediatric Obesity
Progestins
puberty
Puberty
reference ranges
reference value
Reference Values
somatomedin binding protein
somatomedin binding protein 3
somatomedin C
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items